Anika Therapeutics buy B. Riley
Start price
18.04.25
/
50%
€12.10
Target price
18.04.26
-
Performance (%)
-14.05%
Price
27.02.26
€10.40
Summary
This prediction is currently active. The price of Anika Therapeutics has decreased since the start of the prediction. Compared to the start price this results in a performance of -14.05%. This prediction currently runs until 18.04.26. The prediction end date can be changed by B__Riley at any time. B__Riley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Anika Therapeutics | 17.514% | 17.514% |
| iShares Core DAX® | -0,38 % | 1,09 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % |
| iShares S&P 500 | -0,71 % | 0,44 % |
Comments by B__Riley for this prediction
In the thread Anika Therapeutics diskutieren
Anika Therapeutics, Inc. (NASDAQ: ANIK) was upgraded by analysts at B. Riley to a "strong-buy" rating.
Ratings data for ANIK provided by MarketBeat
Stopped prediction by B__Riley for Anika Therapeutics
Anika Therapeutics
Start price
Target price
Perf. (%)
€12.30
17.04.25
17.04.25
€18.48
17.04.26
17.04.26
-26.02%
27.02.26
27.02.26
